CollPlant Biotechnologies Ltd (CLGN) stock
CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
$3.96+0.06 (+1.54%)
Close on Nov 11, 2026Market cap –P/E –Yield –
CollPlant Biotechnologies gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 64.8%, against -215.5% the year before. The highest annual figure on record is 89.6% in fiscal 2017.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 64.8% | +280.3 |
| FY2024 | Dec 31, 2024 | -215.5% | −297.4 |
| FY2023 | Dec 31, 2023 | 81.8% | +115.6 |
| FY2022 | Dec 31, 2022 | -33.8% | −121.0 |
| FY2021 | Dec 31, 2021 | 87.2% | +36.1 |
| FY2020 | Dec 31, 2020 | 51.1% | +32.1 |
| FY2019 | Dec 31, 2019 | 18.9% | −48.0 |
| FY2018 | Dec 31, 2018 | 66.9% | −22.7 |
| FY2017 | Dec 31, 2017 | 89.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -3.9% | −41.8 |
| Q2 FY2024 | Jun 30, 2024 | -115.3% | −124.4 |
| Q2 FY2023 | Jun 30, 2023 | 94.0% | +70.4 |
| Q2 FY2022 | Jun 30, 2022 | 34.8% | −28.3 |
| Q2 FY2021 | Jun 30, 2021 | 37.9% | – |
| Q2 FY2020 | Jun 30, 2020 | 9.1% | – |
| Q2 FY2019 | Jun 30, 2019 | 23.6% | – |
| Q2 FY2018 | Jun 30, 2018 | 63.2% | – |
See a number that looks wrong?